Entos pulls in $53m Series A
Entos, Inc, a creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, has secured $53 million in Series A financing.
Entos, Inc, a creator of a cutting-edge platform combining AI-driven technology and automated synthetic development to design small-molecule therapeutics, has secured $53 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination